Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.
Saved in:
| Title: | Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial. |
|---|---|
| Authors: | Fan Y; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Endocrinology and Metabolism, Minhang Hospital, Fudan University, Shanghai, China., Xia M; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Yan H; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Li X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China., Chang X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Feb; Vol. 26 (2), pp. 772-776. Date of Electronic Publication: 2023 Nov 17. |
| Publication Type: | Randomized Controlled Trial; Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.15359 |
